CVS Health Corporation [NYSE: CVS] jumped around 2.27 points on Monday, while shares priced at $70.62 at the close of the session, up 3.32%. CVS Health Corporation stock is now -4.94% down from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $70.64 and lowest of $68.16 per share. The company’s 52-week high price is 77.03, which means current price is +35.70% above from all time high which was touched on 01/17/20.
Compared to the average trading volume of 10.33M shares, CVS reached a trading volume of 8427338 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Get 12 free stock market lessons delivered to your email from Investor's Business Daily, the leader in investing education for over 35 years. We’ll cover the basics of better investing and show you how to give yourself an edge in the market.
GET FREE LESSON outside the norm.
What do top market gurus say about CVS Health Corporation [CVS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $79.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Credit Suisse have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on May 14, 2020. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on September 27, 2019, representing the official price target for CVS Health Corporation stock.
The Average True Range (ATR) for CVS Health Corporation is set at 1.75, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.35. The Price to Book ratio for the last quarter was 1.42, with the Price to Cash per share for the same quarter was set at 9.73. Price to Free Cash Flow for CVS in the course of the last twelve months was 10.12 with Quick ratio for the last quarter at 0.70.
How has CVS stock performed recently?
CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.59. With this latest performance, CVS shares gained by 14.92% in over the last four-week period, additionally sinking by -5.18% over the last 6 months – not to mention a rise of 30.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 74.71, with the RSI for the last a single of trading hit 81.44, and the three-weeks RSI is set at 66.92 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 62.18, while it was recorded at 67.84 for the last single week of trading, and 66.24 for the last 200 days.
CVS Health Corporation [CVS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +4.95 and a Gross Margin at +17.67. CVS Health Corporation’s Net Margin is presently recorded at +2.58.
Return on Total Capital for CVS is now 8.91, given the latest momentum, and Return on Invested Capital for the company is 4.78. Return on Equity for this stock inclined to 10.86, with Return on Assets sitting at 3.14. When it comes to the capital structure of this company, CVS Health Corporation [CVS] has a Total Debt to Total Equity ratio set at 139.36. Additionally, CVS Total Debt to Total Capital is recorded at 58.22, with Total Debt to Total Assets ending up at 39.68. Long-Term Debt to Equity for the company is recorded at 130.94, with the Long-Term Debt to Total Capital now at 54.70.
Reflecting on the efficiency of the workforce at the company, CVS Health Corporation [CVS] managed to generate an average of $22,859 per employee. Receivables Turnover for the company is 13.78 with a Total Asset Turnover recorded at a value of 1.21.CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.00.
Earnings analysis for CVS Health Corporation [CVS]
With the latest financial reports released by the company, CVS Health Corporation posted 1.89/share EPS, while the average EPS was predicted by analysts to be reported at 1.69/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 11.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 6.05%.
Insider trade positions for CVS Health Corporation [CVS]
There are presently around $69,186 million, or 79.30% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 107,738,750, which is approximately 2.796% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 95,448,551 shares of the stock with an approximate value of $6.52 billion in CVS stocks shares; and STATE STREET CORP, currently with $3.83 billion in CVS stock with ownership of nearly 0.451% of the company’s market capitalization.
Positions in CVS Health Corporation stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 1,033 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 73,505,013 shares. Additionally, 807 investors decreased positions by around 78,524,540 shares, while 141 investors held positions by with 860,197,109 shares. The mentioned changes placed institutional holdings at 1,012,226,662 shares, according to the latest SEC report filing. CVS stock had 159 new institutional investments in for a total of 10,085,971 shares, while 151 institutional investors sold positions of 17,540,123 shares during the same period.